| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,998 |
18,714 |
$1.47M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,669 |
5,621 |
$291K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,492 |
2,167 |
$145K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,846 |
1,740 |
$91K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,773 |
1,622 |
$81K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,116 |
1,067 |
$71K |
| 87631 |
|
781 |
713 |
$59K |
| D1208 |
Topical application of fluoride, excluding varnish |
2,610 |
2,518 |
$31K |
| 92587 |
|
4,198 |
3,798 |
$30K |
| 99383 |
|
361 |
349 |
$25K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
774 |
653 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
8,280 |
7,662 |
$21K |
| 99497 |
|
881 |
669 |
$20K |
| 92551 |
|
4,156 |
3,892 |
$16K |
| 99381 |
|
168 |
160 |
$14K |
| 69210 |
|
938 |
855 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
336 |
320 |
$13K |
| 90686 |
|
1,577 |
1,437 |
$13K |
| 99382 |
|
149 |
144 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
861 |
843 |
$12K |
| 90670 |
|
1,297 |
1,177 |
$12K |
| 99174 |
|
6,356 |
5,829 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
520 |
468 |
$9K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
470 |
461 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
428 |
392 |
$9K |
| 92567 |
|
1,636 |
1,435 |
$8K |
| 81002 |
|
4,660 |
4,367 |
$8K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
54 |
43 |
$7K |
| 90651 |
|
742 |
703 |
$7K |
| 85018 |
|
5,586 |
5,300 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,126 |
1,913 |
$7K |
| 90633 |
|
648 |
595 |
$6K |
| 90680 |
|
594 |
550 |
$5K |
| 90710 |
|
527 |
494 |
$5K |
| 90697 |
|
415 |
408 |
$4K |
| 90700 |
|
436 |
406 |
$4K |
| 90648 |
|
555 |
504 |
$4K |
| 90734 |
|
358 |
333 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
58 |
57 |
$3K |
| 90685 |
|
301 |
267 |
$3K |
| 99460 |
|
31 |
30 |
$3K |
| 99384 |
|
26 |
26 |
$2K |
| 83655 |
|
316 |
295 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
226 |
90 |
$2K |
| 36416 |
|
370 |
347 |
$1K |
| 99188 |
|
692 |
630 |
$1K |
| 90715 |
|
157 |
147 |
$1K |
| 90713 |
|
123 |
114 |
$1K |
| 94060 |
|
77 |
71 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
63 |
60 |
$1K |
| 90620 |
|
116 |
111 |
$1K |
| 17110 |
|
39 |
29 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
18 |
$692.70 |
| 94016 |
|
77 |
71 |
$682.94 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
55 |
52 |
$597.74 |
| 99173 |
|
465 |
458 |
$536.22 |
| 90656 |
|
142 |
140 |
$479.03 |
| 90696 |
|
32 |
30 |
$405.05 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16 |
15 |
$354.39 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
15 |
$354.39 |
| 99072 |
|
2,080 |
1,427 |
$345.00 |
| 87430 |
|
45 |
45 |
$317.52 |
| 90473 |
|
25 |
25 |
$238.56 |
| 90744 |
|
15 |
14 |
$224.09 |
| 94664 |
|
132 |
124 |
$209.66 |
| 90716 |
|
45 |
44 |
$205.56 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
142 |
132 |
$152.69 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
58 |
29 |
$147.44 |
| 90707 |
|
29 |
29 |
$58.74 |
| 96127 |
|
18 |
18 |
$30.56 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
13 |
$3.06 |
| G0009 |
Administration of pneumococcal vaccine |
44 |
38 |
$0.15 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
35 |
34 |
$0.00 |
| 96160 |
|
15 |
15 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
671 |
599 |
$0.00 |